The Vaccine Evaluation Group is dedicated to every stage of vaccine research, from initial clinical trials to comprehensive program assessments, specializing in developing and conducting first-in-human phase 1 studies, as well as post-licensure phase 4 trials. The Evaluation Group works with external partners to evaluate the real-world effectiveness of vaccines, examining their impact on disease burden, vaccine compliance, and public acceptance.
The Group plays a key role in the Center’s integrated, multi-disciplinary vaccine research approach, partnering closely with industry, external organizations, and the Vaccine Discovery and the Policy, Programs and Implementation (PPI) Groups to drive innovation and public health progress.
